EN
HI
Biocon Chart
Biocon Share Key Metrics
Volume
33.61 L
Market Cap
67308.20 CR
LTQ@LTP
26@416.65
ATP
414.2
Var Margin
14.9 %
Circuit Range
373.75-456.75
Delivery %
53.45 %
Value
139.19 CR
ASM/GSM
No
Market Lot
1
Summary
Biocon share price is ₹416.65 as of 30 Jun, 2026. The stock Biocon intraday movement has stayed between ₹411.20 and ₹418.55, while on a 52-week basis,Biocon price 52 week high is ₹440.40 & its 52 week low is ₹331.00.
In terms of trading activity, Biocon has recorded a volume of 3360533 shares, The Biocon has a market cap of ₹1620907773 CR. The stock’s Average Traded Price (ATP) stands at ₹414.20, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 26 @ ₹416.65.
Biocon operates within a circuit range of ₹373.75 – ₹456.75, with a Value of ₹139.19 CR. The Delivery Percentage for the day is 53.45%. Additionally, Biocon currently falls under the No framework, and trades with a market lot size of 1.
Biocon Fundamentals
P/E Ratio
174.55
P/B Ratio
1.98
Div. Yield
0.12
Sector P/E
70.04
Sector P/B
3.18
Sec. Div. Yield
0.53
Biocon Resistance and Support
Pivot 416.85
Resistance
First Resistance
420.2
Second Resistance
425.15
Third Resistance
428.5
Support
First Support
411.9
Second Support
408.55
Third Support
403.6
Biocon Futures & Options
Biocon Option Chain
View Price, OI, Greeks & More...
30JUN26
416.30
0.50 (0.12%)
28JUL26
418.90
1.75 (0.42%)
25AUG26
421.70
1.80 (0.43%)
BIOCON|30JUN26 CE 415.00
2.50
-0.7 (-21.88%)
BIOCON|30JUN26 PE 420.00
3.25
-2.25 (-40.91%)
Biocon Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-10-01 | Redemption (Part) of NCD |
| 2025-08-07 | Quarterly Results |
| 2025-05-08 | Audited Results & Final Dividend |
| 2025-04-23 | Others |
| 2025-04-04 | To consider Fund Raising |
| 2025-01-30 | Quarterly Results & Others |
| 2025-01-27 | Others |
Biocon News
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Biocon completed the acquisition of the remaining 1,15,36,956 equity shares of its material subsidiary, Biocon Biologics Limited (BBL), from 127 selling shareholders. This makes BBL a wholly-owned subsidiary of Biocon, strengthening its control and operational integration.
Jun 29 2026 22:35:24
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Allotment
Biocon allotted 8.78 million fully paid-up equity shares at Rs. 376.41 each on a preferential basis. This allotment was to 127 selling shareholders of Biocon Biologics Limited (BBL) as consideration for acquiring their remaining shares, making BBL a wholly-owned subsidiary.
Jun 29 2026 22:33:28
Read More
Biocon Management
| Name | Position |
|---|---|
| Kiran Mazumdar-Shaw | Chairperson |
| Ravi Rasendra Mazumdar | Non Independent & Non Executive Director |
Biocon Similar Stocks
Mankind Pharma Ltd.
2532.50
46.50 (1.87%)
Aurobindo Pharma Ltd.
1581.70
34.20 (2.21%)
Lenskart Solutions Ltd.
514.95
9.10 (1.80%)
Laurus Labs Ltd.
1504.50
4.20 (0.28%)
Fortis Healthcare Ltd.
961.05
10.65 (1.12%)
Alkem Laboratories Ltd.
5520.00
103.50 (1.91%)
Glenmark Pharmaceuticals Ltd.
2204.50
17.90 (0.82%)
Abbott India Ltd.
25410.00
115.00 (0.45%)
Anthem Biosciences Ltd.
774.30
-0.70 (0.09%)
Biocon FAQs
The Buying Price of Biocon share is 416.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Biocon stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biocon, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Biocon shares is 174.55. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Biocon shares is 1.98. Useful to assess the stock's value relative to its book value.
To assess Biocon’s valuation compare Sector P/E, P/B which are 70.04 & 3.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Biocon is 67308.20 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Biocon share price is 440.40 & 331.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Biocon belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
